Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation
- PMID: 24495951
- PMCID: PMC3999970
- DOI: 10.1177/1535370213514927
Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation
Abstract
DNA methylation and histone acetylation contribute to the transcriptional regulation of genes involved in apoptosis. We have demonstrated that docosahexaenoic acid (DHA, 22:6 n-3) and butyrate enhance colonocyte apoptosis. To determine if DHA and/or butyrate elevate apoptosis through epigenetic mechanisms thereby restoring the transcription of apoptosis-related genes, we examined global methylation; gene-specific promoter methylation of 24 apoptosis-related genes; transcription levels of Cideb, Dapk1, and Tnfrsf25; and global histone acetylation in the HCT-116 colon cancer cell line. Cells were treated with combinations of (50 µM) DHA or linoleic acid (18:2 n-6), (5 mM) butyrate or an inhibitor of DNA methyltransferases, and 5-aza-2'-deoxycytidine (5-Aza-dC, 2 µM). Among highly methylated genes, the combination of DHA and butyrate significantly reduced methylation of the proapoptotic Bcl2l11, Cideb, Dapk1, Ltbr, and Tnfrsf25 genes compared to untreated control cells. DHA treatment reduced the methylation of Cideb, Dapk1, and Tnfrsf25. These data suggest that the induction of apoptosis by DHA and butyrate is mediated, in part, through changes in the methylation state of apoptosis-related genes.
Keywords: DNA methylation; apoptosis; butyrate; docosahexaenoic acid; epigenetics.
Figures




References
-
- Bird A. Perceptions of epigenetics. Nature. 2007;447:396–8. - PubMed
-
- Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148–59. - PubMed
-
- Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4:988–93. - PubMed
-
- Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, Wolff RK, Slattery ML. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837–45. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA057030/CA/NCI NIH HHS/United States
- CA057030/CA/NCI NIH HHS/United States
- R01 CA057030/CA/NCI NIH HHS/United States
- R01 CA059034/CA/NCI NIH HHS/United States
- CA90301/CA/NCI NIH HHS/United States
- CA59034/CA/NCI NIH HHS/United States
- CA61750/CA/NCI NIH HHS/United States
- R01 CA061750/CA/NCI NIH HHS/United States
- R37 CA057030/CA/NCI NIH HHS/United States
- R01 CA168312/CA/NCI NIH HHS/United States
- CA129444/CA/NCI NIH HHS/United States
- CA168312/CA/NCI NIH HHS/United States
- R01 CA129444/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources